CWEB

Charlotte's Web Launches" Stay Asleep" CBN Gummies

Retrieved on: 
Tuesday, March 19, 2024

LOUISVILLE, Colo., March 19, 2024 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the leading provider of hemp-derived CBD wellness products, has formally launched its latest innovation, "Stay Asleep" CBN Gummies.

Key Points: 
  • LOUISVILLE, Colo., March 19, 2024 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the leading provider of hemp-derived CBD wellness products, has formally launched its latest innovation, "Stay Asleep" CBN Gummies.
  • The launch of Charlotte's Web Stay Asleep CBN Gummies is a testament to this commitment.
  • Developed under the leadership of Charlotte's Web's Chief Scientific Officer, Dr. Marcel Bonn-Miller, the Stay Asleep CBN Gummies demonstrate Charlotte's Web commitment to science-backed products, providing an effective alternative to more traditional sleep supplements and medications.
  • With millions of Americans grappling with sleep issues1, the Stay Asleep CBN Gummies embody Charlotte's Web's mission to unearth the science of nature to revolutionize wellness.

Charlotte's Web 2023 Fourth Quarter and Year-End Earnings Call and Webcast Notice

Retrieved on: 
Tuesday, March 5, 2024

LOUISVILLE, Colo., March 5, 2024 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") the market leader in cannabidiol (CBD) hemp extract wellness products , will report its 2023 fourth quarter and year-end results prior to market open on March 21, 2024.

Key Points: 
  • LOUISVILLE, Colo., March 5, 2024 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") the market leader in cannabidiol (CBD) hemp extract wellness products , will report its 2023 fourth quarter and year-end results prior to market open on March 21, 2024.
  • A conference call to discuss the results is scheduled for the same day at 11:00 a.m. Eastern Time.
  • To listen to a replay of the earnings call please dial 1-416-764-8677 or 1-888-390-0541 and provide conference replay ID 481810#.
  • A webcast of the call will also be accessible through the investor relations section of the Company's website for an extended period of time.

Charlotte's Web Holdings Inc. Announces Appointment of former Ben & Jerry's CEO, Matthew E. McCarthy, to its Board of Directors

Retrieved on: 
Wednesday, February 7, 2024

Mr. McCarthy is the former CEO of Ben & Jerry's Homemade ("Ben & Jerry's"), bringing a unique blend of commercial acumen and deep commitment to social impact within the consumer-packaged goods (CPG) and natural products industries.

Key Points: 
  • Mr. McCarthy is the former CEO of Ben & Jerry's Homemade ("Ben & Jerry's"), bringing a unique blend of commercial acumen and deep commitment to social impact within the consumer-packaged goods (CPG) and natural products industries.
  • He was also a member of Ben & Jerry's Board of Directors.
  • Mr. McCarthy replaces Susan Vogt who is retiring from Charlotte's Web Board.
  • His notable career is complemented by numerous recognitions and awards, reflecting his commitment to business excellence and ethical leadership.

DeFloria LLC Commences Phase 1 Clinical Program for Innovative Full Spectrum Hemp Botanical Drug

Retrieved on: 
Wednesday, December 13, 2023

We are proud of our team's hard work reach this point, and I am excited to help develop the Phase 2 program for this new drug."

Key Points: 
  • We are proud of our team's hard work reach this point, and I am excited to help develop the Phase 2 program for this new drug."
  • "The initiation of the AJA001 clinical program serves as an important milestone for DeFloria.
  • At DeFloria, we have united the early leaders in CBD with the finest minds in clinical and biotechnological research.
  • Following completion of this Phase 1 study, DeFloria plans to submit an Investigational New Drug (IND) application to the Food and Drug Administration (FDA) to commence the Phase 2 clinical program for AJA001.

CBD Consumer, Science and Policy Experts Joined ONE HEMP in D.C. Briefing to Urge Congress to Meet the Market Where It is

Retrieved on: 
Thursday, December 7, 2023

"The message of today's briefing was clear – the supply chain bottleneck caused by lack of regulation is negatively impacting millions of CBD consumers, farmers and manufacturers.

Key Points: 
  • "The message of today's briefing was clear – the supply chain bottleneck caused by lack of regulation is negatively impacting millions of CBD consumers, farmers and manufacturers.
  • ONE HEMP has provided sensible policy solutions backed by science to open a pathway for a safe, standardized CBD industry.
  • Retailers want to sell CBD products and consumers want to access to them."
  • The nation's hemp and CBD producers, and the millions of Americans who rely on their products, will all benefit from a clear regulatory framework for CBD products.

Charlotte's Web Reports 2023 Third Quarter Financial Results

Retrieved on: 
Thursday, November 9, 2023

New CEO Reinvigorates Organizational Focus and Strategic Discipline; Washington D.C. Making Headway on Federal CBD Regulatory Framework

Key Points: 
  • New CEO Reinvigorates Organizational Focus and Strategic Discipline; Washington D.C. Making Headway on Federal CBD Regulatory Framework
    LOUISVILLE, Colo., Nov. 9, 2023 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the third quarter ended September 30, 2023.
  • On September 13, 2023, Charlotte's Web appointed Bill Morachnick, Chief Executive Officer of the Company.
  • "Since I joined Charlotte's Web in the late third quarter, I have been truly impressed by the talent, passion, and scientific expertise within the company," stated Bill Morachnick, the CEO of Charlotte's Web.
  • In early 2023, Charlotte's Web initiated a plan to move the production of topical products in-house.

Charlotte's Web Appoints Angela McElwee, Former CEO of Gaia Herbs, to Board of Directors

Retrieved on: 
Thursday, October 12, 2023

Angela McElwee is a seasoned executive with expertise in building businesses and brands within the natural products industry.

Key Points: 
  • Angela McElwee is a seasoned executive with expertise in building businesses and brands within the natural products industry.
  • From April 2008 to January 2021, she was an executive at Gaia Herbs, Inc. ("Gaia"), where she also served on the Board of Directors from 2013-2021.
  • Gaia Herbs is an award-winning natural herbal products brand offering more than 200 quality herbal products in North America.
  • She currently serves on the Board of Directors of Cyanotech Inc. a Nasdaq-listed company, where she serves on the Audit Committee.

CBD Industry Leader Charlotte's Web Joins Historic Alliance ONE HEMP to Support FDA Regulation

Retrieved on: 
Tuesday, September 19, 2023

The time for the CBD industry and Congress to act is long overdue," said Jared Stanley, Co-Founder and Chief Operating Officer of Charlotte's Web.

Key Points: 
  • The time for the CBD industry and Congress to act is long overdue," said Jared Stanley, Co-Founder and Chief Operating Officer of Charlotte's Web.
  • "A decade has passed since hemp-based CBD became a wellness choice for more than 45 million daily American CBD consumers*.
  • ONE HEMP unites leading CBD industry stakeholders in a pivotal moment to work toward more stringent regulatory standards, including independent third-party testing and accurate labeling.
  • Charlotte's Web and ONE HEMP invite CBD industry partners who seek the regulatory standards that consumers deserve to join this historic coalition.

Charlotte's Web Announces Appointment of Bill Morachnick as Chief Executive Officer

Retrieved on: 
Wednesday, September 13, 2023

LOUISVILLE, Colo., Sept. 13, 2023 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") is pleased to announce the appointment of William (Bill) Morachnick who has joined the Company as its Chief Executive Officer.

Key Points: 
  • LOUISVILLE, Colo., Sept. 13, 2023 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") is pleased to announce the appointment of William (Bill) Morachnick who has joined the Company as its Chief Executive Officer.
  • Mr. Morachnick has also been appointed to the Company's Board of Directors as a non-independent director.
  • Mr. Morachnick led the subsequent integration of the combined companies as Chief Executive Officer and Chairman based in Tokyo, Japan for two years before returning to the U.S. in 2018.
  • "Bill has an accomplished career building businesses in multiple categories," said John Held, Chairman of Charlotte's Web.

Charlotte's Web Reports 2023 Second Quarter Financial Results

Retrieved on: 
Thursday, August 10, 2023

Net revenue of $16.0M vs. $18.9M YoY

Key Points: 
  • Net revenue of $16.0M vs. $18.9M YoY
    LOUISVILLE, Colo., Aug. 10, 2023 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the second quarter ended June 30, 2023.
  • During the second quarter, the U.S. Food and Drug Administration ("FDA") committed to "work at speed" with Congress to resolve a regulatory pathway for hemp-derived CBD.
  • Recent progress has been encouraging surrounding The Hemp Derived Consumer Protection and Market Stabilization Act of 2023, (bill H.R.
  • Charlotte's Web and industry peers have compiled and shared safety and toxicology data with Congress to address concerns raised by the FDA.